AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 36 filers reported holding AXSOME THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $5,248,000 | +903.4% | 259,310 | +1176.8% | 1.69% | +1241.3% |
| Q2 2019 | $523,000 | -13.3% | 20,310 | -52.1% | 0.13% | -22.7% |
| Q1 2019 | $603,000 | -43.9% | 42,410 | -88.9% | 0.16% | -58.3% |
| Q4 2018 | $1,074,000 | -25.3% | 380,812 | -8.6% | 0.39% | -20.7% |
| Q3 2018 | $1,437,000 | +132.1% | 416,458 | +115.5% | 0.49% | +44.2% |
| Q2 2018 | $619,000 | +30.6% | 193,290 | 0.0% | 0.34% | +20.0% |
| Q1 2018 | $474,000 | -46.1% | 193,290 | +20.8% | 0.28% | -31.8% |
| Q2 2017 | $880,000 | +7.4% | 160,000 | -23.8% | 0.42% | -8.7% |
| Q1 2017 | $819,000 | – | 210,000 | – | 0.46% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 788,263 | $35,172,000 | 44.43% |
| Fairmount Funds Management LLC | 1,896,647 | $84,628,000 | 14.88% |
| ACT CAPITAL MANAGEMENT, LLC | 73,000 | $3,257,000 | 4.50% |
| Ghost Tree Capital, LLC | 300,000 | $13,386,000 | 3.76% |
| Ikarian Capital, LLC | 407,600 | $18,188,000 | 3.62% |
| Paradigm Biocapital Advisors LP | 520,080 | $23,206,000 | 3.09% |
| MORGAN JESS S & CO INC | 78,895 | $3,520,000 | 3.06% |
| PFM Health Sciences, LP | 1,659,733 | $74,057,000 | 2.68% |
| RTW INVESTMENTS, LP | 1,882,164 | $83,982,000 | 1.94% |
| Ghost Tree Capital, LLC | 150,000 | $6,693,000 | 1.88% |